Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)- induced colitis

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 51-58

  Murano, M ^a   Maemura, K ^a   Hirata, I ^a   Toshina, K ^a   Nishikawa, T ^a   Hamamoto, N ^a   Sasaki, S ^a   Saitoh, O ^a   Katsu, K ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antisense oligonucleotide; Dextran sulphate sodium; Inflammatory bowel disease; NF B

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; COLITIS; COLON MUCOSA; COMPLEX FORMATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENTERITIS; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0034124076     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01183.x     Document Type: Article

References (30)

1. Stanley R, Hamilton Basil C. Gastroenterology, 5th edn. Bockus: Morison, 1991:1326-37.
2. Das KM, Dasgupta A, Madal A, Geng X. Autoimmunity to cytoskeletal protein tropomyosin. J Immunol 1993; 150:2487-93.
3. Reinacker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
4. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J, Gross V, Falk W. Neutralization of tumor necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulfate sodium-induced colitis in mice. Clin Exp Immunol 1997; 107:353-8.
5. Bennett CF, Kornbrust D, Henry S et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 1997; 280:988-1000.
6. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996; 87:13-20.
7. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κ in inflammatory bowel disease. Gut 1998; 42:477-84.
8. Neurath MF. Pathogenesis of inflammatory bowel disease: transcription factors in the spotlight. Gut 1998; 42:458-9.
9. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12:149-79.
10. Rogler G, Brand K, Vogl D et al. Nuclear factor B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998; 115:357-69.
11. Murthy SNS, Cooper HS, Shim H, Shah RS, Ibarahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38:1722-34.
12. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM. Regulation of interleukin 12 p40 expression through a NF-κB half-site. Mol Cell Biol 1995; 15:5258-67.
13. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69:238-49.
14. Hume DA, Robinson AP, Macpherson GG, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of the antigen F4/80; relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med 1983; 158:1522-36.
15. Whiteland JL, Nicholls SM, Shimeld C, Easty DL, William NA, Hill TJ. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 1995; 43:313-20.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning; a laboratory manual, 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989:18.60-18.63.
17. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin As Jr. Role of transcriptional activation by IκB in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283-6.
18. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NFκB activity through induction of IκB synthesis. Science 1995; 270:286-90.
19. Aruoma OI, Wasil H, Halliwell B, Hoey BM, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. Biochem Pharmacol 1987; 36:3739-42.
20. Gionchetti P, Guarnieri C, Campieri M, Belluzzi A, Brignola C, Iannone P, Miglioli M, Barbara L. Scavenger effect of salfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation. Dig Dis Sci 1991; 36:174-8.
21. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101:1163-74.
22. Neurath MF, Pettersson S, Hermann K, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Med 1996; 2:998-1004.
23. Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora. Jpn J Gastroenterol 1985; 82:1327-36.
24. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694-702.
25. Takizawa H, Sasakawa T, Nakazawa T et al. Dynamics of immunocompetent cell in colitis mucosa induced by dextran sulfate in rats. In: Tsuchiya M, Nagura H, Hibi T. Frontiers of mucosal immunology. Amsterdam: Excerpta Medica, 1991:853-4.
26. Shintani N, Nakajima T, Nakakubo H, Nagai H, Kagitani Y, Takizawa H, Asakura H. Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats. Clin Exp Immunol 1997; 108:340-5.
27. Ni J, Chen SF, Hollander D. Effects of dextran sulfate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996; 39:234-41.
28. Kitajima I, Sinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M. Ablation of transplanted HTLV-I tax transformed tumors in mice by antisense inhibition of NF-κB. Science 1992; 258:1792-5.
29. Funatomi H, Itakura J, Ishiwata T, Pastan I, Thompson SA, Johnson GR, Korc M. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer 1997; 72:512-7.
30. Yacyshyn BR, Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan Wr Jr. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 1998; 114:1133-42.